Mind Club

Data as of 11.07.2026 · Primary sources linked · NOT INVESTMENT ADVICE

Disease Pipeline Tools Obesity

Obesity

Programs, trials, and reported weight change for obesity and overweight.

Data as of 11.07.2026

All studies

Beloranib

bestPWS

Zafgen · Phase 3 · Terminated · Enrollment 108

NCT02179151

ArmPopulationDoseWeeksEstimandWeight change
PlaceboObesity or overweightn/r28n/rn/r
ZGN-440 Injectable Suspension (1.8 mg)Obesity or overweight1.8 mg28n/rn/r
ZGN-440 Injectable Suspension (2.4 mg)Obesity or overweight2.4 mg28n/rn/r